お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
986436

遺伝子治療市場 - 市場シェア、市場規模、動向、業界分析:2021年~2028年

Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Vector Type ; By Approach ; By Therapeutic Area; By Route of Administration; By Regions; Segment Forecast, 2021 - 2028

出版日: | 発行: Polaris Market Research | ページ情報: 英文 132 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.75円
遺伝子治療市場 - 市場シェア、市場規模、動向、業界分析:2021年~2028年
出版日: 2021年01月01日
発行: Polaris Market Research
ページ情報: 英文 132 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子治療の市場規模は、2028年までに50億2,000万米ドルに達すると予測されています。遺伝性疾患や腫瘍疾患などの慢性疾患の有病率の上昇、関連分野における臨床試験数の急増、規制当局からの製品承認の増加が、市場の成長を促進する要因の一部です。

当レポートでは、世界の遺伝子治療市場について調査分析し、現在の市場力学に関する詳細な考察、将来の市場成長に対する分析について、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 遺伝子治療市場の考察

  • 遺伝子治療:業界のスナップショット
  • 遺伝子治療市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
  • PESTLE分析
  • 遺伝子治療市場の業界動向

第5章 世界の遺伝子治療市場:治療分野別

  • 主な調査結果
  • イントロダクション
  • 自己免疫疾患
  • 心血管疾患
  • 皮膚疾患
  • 遺伝性疾患
  • 血液疾患
  • 眼科疾患
  • 代謝障害
  • 筋肉関連疾患
  • 腫瘍疾患
  • その他

第6章 世界の遺伝子治療市場:ベクタータイプ別

  • 主な調査結果
  • イントロダクション
  • ウイルス
  • 非ウイルス

第7章 世界の遺伝子治療市場:アプローチ別

  • 主な調査結果
  • イントロダクション
  • 増殖
  • 腫瘍溶解性ウイルス療法
  • 免疫療法
  • その他

第8章 遺伝子治療市場評価:投与経路別

  • 主な調査結果
  • イントロダクション
  • 関節内
  • 小脳内
  • 皮内
  • 筋肉内
  • 腫瘍内
  • 静脈内
  • 膀胱内
  • 硝子体内
  • 網膜下
  • その他

第9章 遺伝子治療市場評価:地域別

  • 主な調査結果
  • イントロダクション
  • 遺伝子治療市場:北米
  • 遺伝子治療市場:欧州
  • 遺伝子治療市場:アジア太平洋地域
  • 遺伝子治療市場:中東・アフリカ
  • 遺伝子治療市場:ラテンアメリカ

第10章 競合情勢

  • 拡張と買収の分析
  • パートナーシップ/コラボレーション/契約/公開

第11章 企業プロファイル

  • Novartis AG
  • Spark Therapeutics LLC
  • Bluebird Bio
  • Gilead Sciences Inc.
  • Celgene Corporation
  • GlaxoSmithKline
  • Sangamo Biosciences
  • Voyager Therapeutics
  • Dimension Therapeutics
図表

List of Tables

  • Table 1 Global Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 2 Global Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 3 Global Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 4 Global Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 5 Gene Therapy Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • Table 6 North America: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 7 North America: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 8 North America: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 9 North America: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 10 U.S.: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 11 U.S.: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 12 U.S.: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 13 U.S.: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 14 Canada: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 15 Canada: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 16 Canada: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 17 Canada: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 18 Europe: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 19 Europe: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 20 Europe: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 21 Europe: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 22 UK: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 23 UK: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 24 UK: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 25 UK: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 26 France: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 27 France: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 28 France: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 29 France: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 30 Germany: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 31 Germany: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 32 Germany: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 33 Germany: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 34 Italy: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 35 Italy: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 36 Italy: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 37 Italy: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 38 Spain: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 39 Spain: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 40 Spain: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 41 Spain: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 42 Netherlands: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 43 Netherlands: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 44 Netherlands: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 45 Netherlands: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 46 Austria: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 47 Austria: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 48 Austria: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 49 Austria: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 50 Asia Pacific: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 51 Asia Pacific: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 52 Asia Pacific: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 53 Asia Pacific: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 54 China: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 55 China: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 56 China: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 57 China: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 58 India: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 59 India: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 60 India: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 61 India: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 62 Malaysia: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 63 Malaysia: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 64 Malaysia: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 65 Malaysia: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 66 Japan: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 67 Japan: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 68 Japan: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 69 Japan: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 70 Indonesia: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 71 Indonesia: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 72 Indonesia: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 73 Indonesia: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 74 South Korea: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 75 South Korea: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 76 South Korea: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 77 South Korea: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 78 Middle East & Africa: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 79 Middle East & Africa: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 80 Middle East & Africa: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 81 Middle East & Africa: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 82 Saudi Arabia: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 83 Saudi Arabia: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 84 Saudi Arabia: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 85 Saudi Arabia: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 86 UAE: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 87 UAE: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 88 UAE: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 89 UAE: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 90 Israel: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 91 Israel: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 92 Israel: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 93 Israel: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 94 South Africa: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 95 South Africa: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 96 South Africa: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 97 South Africa: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 98 Latin America: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 99 Latin America: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 100 Latin America: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 101 Latin America: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 102 Mexico: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 103 Mexico: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 104 Mexico: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 105 Mexico: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 106 Brazil: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 107 Brazil: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 108 Brazil: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 109 Brazil: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • Table 110 Argentina: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 111 Argentina: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • Table 112 Argentina: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • Table 113 Argentina: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)

List of Figures

Figure 1 Market Highlights (2020, Revenue)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top-Down & Bottom-Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by Therapeutic Area

Figure 7 Global Gene Therapy Market, By Therapeutic Area, 2020 & 2028 (USD Million)

Figure 8 Market by Vector Type

Figure 9 Global Gene Therapy Market, By Vector Type, 2020 & 2028 (USD Million)

Figure 10 Market by Approach

Figure 11 Global Gene Therapy Market, By Approach, 2020 & 2028 (USD Million)

Figure 12 Gene Therapy Market Assessment, By Geography, 2016 - 2028 (USD Million)

Figure 13 Strategic Analysis - Gene Therapy Market

目次
Product Code: PM1084

Title:
Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Vector Type (Viral, Non-viral); By Approach (Gene Augmentation, Oncolytic Viral Therapy, Immunotherapy, Others); By Therapeutic Area; By Route of Administration; By Regions; Segment Forecast, 2021 - 2028.

The global gene therapy market expected to reach USD 5.02 billion by 2028, according to a new study by Polaris Market Research. The report "Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Vector Type (Viral, Non-viral); By Approach (Gene Augmentation, Oncolytic Viral Therapy, Immunotherapy, Others); By Therapeutic Area; By Route of Administration; By Regions; Segment Forecast, 2021 - 2028" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of chronic disorders including heredity and oncology diseases, rise in the number of clinical trials in the concerned arena, and increase in product approvals from regulatory agencies are few factors boosting the market growth. Moreover, innovations in the gene delivery systems also expedited the demand for such products.

The market is fragmented based on the therapy area, vector type, approach, route of administration, and region. In terms of therapeutic area, the market is segmented into autoimmune disorders, cardiovascular diseases, dermatological disorders, genetic disorders, hematological disorders, metabolic disorders, muscle-related diseases, oncological disorders, ophthalmic diseases, and others.

Based on the vector type, the industry is further bifurcated into viral and non-viral vectors. Based on the approach, the industry is further bifurcated into gene augmentation, oncolytic viral therapy, immunotherapy, and others. Based on the route of administration, the market is further bifurcated into intraarticular, intracerebellar, intradermal, intramuscular, intratumoral, intravenous, intravesical, intravitreal, subretinal, and others.

Segment Highlights

The genetic disorders segment accounted for the largest revenue share in 2020 owing to the emergence of novel disorders and associated research and innovation. Furthermore, the increasing number of genetic disorders is expected to drive segment growth.

Based on the vector type, the viral segment accounted for over 55% in terms of revenue in 2020. This can be attributed to its high accuracy in gene delivery and the presence of several players across the market.

North America region is dominating the global market, holding almost one-third of the market share throughout the forecast period. Positive funding scenario and the presence of competent regulatory authorities favoring the growth in the region

The players including Novartis AG, Celgene Corporation, and Gilead Sciences Inc. together account for a significant market share of the global market in the year 2020

List of Key Players:

Dimension Therapeutics

Novartis AG

Bluebird Bio

Gilead Sciences Inc.

Human Stem Cell Institute

Spark Therapeutics

Celgene Corporation

Sangamo Biosciences

GlaxoSmithKline

Bristol Myer's Squibb

Celgene Corporation

Others

Polaris Market Research has segmented the gene therapy market report on the basis of therapeutic area, vector type, approach, route of administration, and region

Gene Therapy, Therapeutic Area Outlook (Revenue - USD Million, 2016 - 2028)

Autoimmune Disorders

Cardiovascular Diseases

Dermatological Disorders

Genetic Disorders

Hematological Disorders

Metabolic Disorders

Muscle-related Diseases

Oncological Disorders

Ophthalmic Diseases

Others

Gene Therapy, Vector Type Outlook (Revenue - USD Million, 2016 - 2028)

Viral

Retroviral vectors

Gamma-retroviral vectors

Lentiviral vectors

Adeno-associated virus vectors

other viral vectors

Non-viral

Oligonucleotides

Other non-viral vectors

Gene Therapy, Approach Outlook (Revenue - USD Million, 2016 - 2028)

Augmentation

Oncolytic Viral Therapy

Immunotherapy

Others

Gene Therapy, Route of Administration Outlook (Revenue - USD Million, 2016 - 2028)

Intraarticular

Intracerebellar

Intradermal

Intramuscular

Intratumoral

Intravenous

Intravesical

Intravitreal

Subretinal

Others

Gene Therapy, Regional Outlook (Revenue - USD Million, 2016 - 2028)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Central & South America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Gene Therapy Market Insights

  • 4.1. Gene Therapy - Industry snapshot
  • 4.2. Gene Therapy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing incidence of cancer and target diseases
      • 4.2.1.2. Research and funding in gene therapy
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High treatment cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Gene Therapy Market Industry trends

5. Gene Therapy Market Assessment by Therapeutic Area

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • 5.3. Autoimmune Disorders
    • 5.3.1. Global Gene Therapy Market, by Autoimmune Disorders, by Region, 2016 - 2028 (USD Million)
  • 5.4. Cardiovascular Diseases
    • 5.4.1. Global Gene Therapy Market, by Cardiovascular Diseases, by Region, 2016 - 2028 (USD Million)
  • 5.5. Dermatological Disorders
    • 5.5.1. Global Gene Therapy Market, by Dermatological Disorders, by Region, 2016 - 2028 (USD Million)
  • 5.6. Genetic Disorders
    • 5.6.1. Global Gene Therapy Market, by Genetic Disorders, by Region, 2016 - 2028 (USD Million)
  • 5.7. Hematological Disorders
    • 5.7.1. Global Gene Therapy Market, by Hematological Disorders, by Region, 2016 - 2028 (USD Million)
  • 5.8. Ophthalmic Diseases
    • 5.8.1. Global Gene Therapy Market, by Ophthalmic Diseases, by Region, 2016 - 2028 (USD Million)
  • 5.9. Metabolic Disorders
    • 5.9.1. Global Gene Therapy Market, by Metabolic Disorders, by Region, 2016 - 2028 (USD Million)
  • 5.10. Muscle-related Diseases
    • 5.10.1. Global Gene Therapy Market, by Muscle-related Diseases, by Region, 2016 - 2028 (USD Million)
  • 5.11. Oncological Disorders
    • 5.11.1. Global Gene Therapy Market, by Oncological Disorders, by Region, 2016 - 2028 (USD Million)
  • 5.12. Others
    • 5.12.1. Global Gene Therapy Market, by Others, by Region, 2016 - 2028 (USD Million)

6. Global Gene Therapy Market, by Vector Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
  • 6.3. Viral
    • 6.3.1. Global Gene Therapy Market, by Viral Vectors, By Region, 2016 - 2028 (USD Million)
    • 6.3.2. Retroviral Vectors
      • 6.3.2.1. Global Gene Therapy Market, by Retroviral Vectors, by Region, 2016 - 2028 (USD Million)
      • 6.3.2.2. Gamma-retroviral Vectors
      • 6.3.2.2.1. Global Gene Therapy Market, by Gamma-retroviral Vectors, by Region, 2016 - 2028 (USD Million)
      • 6.3.2.3. Lentiviral Vectors
      • 6.3.2.3.1. Global Gene Therapy Market, by Lentiviral Vectors, by Region, 2016 - 2028 (USD Million)
    • 6.3.3. Adeno-associated Virus Vectors
      • 6.3.3.1. Global Gene Therapy Market, by Adeno-associated Virus Vectors, by Region, 2016 - 2028 (USD Million)
    • 6.3.4. Other Viral Vectors
      • 6.3.4.1. Global Gene Therapy Market, by Other Viral Vectors, by Region, 2016 - 2028 (USD Million)
  • 6.4. Non-viral
    • 6.4.1. Global Gene Therapy Market, by Non-viral Vectors, By Region, 2016 - 2028 (USD Million)
    • 6.4.2. Oligonucleotides
      • 6.4.2.1. Global Gene Therapy Market, by Oligonucleotides, By Region, 2016 - 2028 (USD Million)
    • 6.4.3. Other Non-viral Vectors
      • 6.4.3.1. Global Gene Therapy Market, by Other Non-viral Vectors, By Region, 2016 - 2028 (USD Million)

7. Global Gene Therapy Market, by Approach

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
  • 7.3. Augmentation
    • 7.3.1. Global Gene Therapy Market, by Augmentation, By Region, 2016 - 2028 (USD Million)
  • 7.4. Oncolytic Viral Therapy
    • 7.4.1. Global Gene Therapy Market, by Oncolytic Viral Therapy, by Region, 2016 - 2028 (USD Million)
  • 7.5. Immunotherapy
    • 7.5.1. Global Gene Therapy Market, by Immunotherapy, by Region, 2016 - 2028 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Gene Therapy Market, by Others, by Region, 2016 - 2028 (USD Million)

8. Gene Therapy Market Assessment by Route of Administration

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • 8.3. Intraarticular
    • 8.3.1. Global Gene Therapy Market, by Intraarticular, by Region, 2016 - 2028 (USD Million)
  • 8.4. Intracerebellar
    • 8.4.1. Global Gene Therapy Market, by Intracerebellar, by Region, 2016 - 2028 (USD Million)
  • 8.5. Intradermal
    • 8.5.1. Global Gene Therapy Market, by Intradermal, by Region, 2016 - 2028 (USD Million)
  • 8.6. Intramuscular
    • 8.6.1. Global Gene Therapy Market, by Intramuscular, by Region, 2016 - 2028 (USD Million)
  • 8.7. Intratumoral
    • 8.7.1. Global Gene Therapy Market, by Intratumoral, by Region, 2016 - 2028 (USD Million)
  • 8.8. Intravenous
    • 8.8.1. Global Gene Therapy Market, by Intravenous, by Region, 2016 - 2028 (USD Million)
  • 8.9. Intravesical
    • 8.9.1. Global Gene Therapy Market, by Intravesical, by Region, 2016 - 2028 (USD Million)
  • 8.10. Intravitreal
    • 8.10.1. Global Gene Therapy Market, by Intravitreal, by Region, 2016 - 2028 (USD Million)
  • 8.11. Subretinal
    • 8.11.1. Global Gene Therapy Market, by Subretinal, by Region, 2016 - 2028 (USD Million)
  • 8.12. Others
    • 8.12.1. Global Gene Therapy Market, by Others, by Region, 2016 - 2028 (USD Million)

9. Gene Therapy Market Assessment by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Gene Therapy Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • 9.3. Gene Therapy Market - North America
    • 9.3.1. North America: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 9.3.2. North America: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
    • 9.3.3. North America: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
    • 9.3.4. North America: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.3.5. Gene Therapy Market - U.S.
      • 9.3.5.1. U.S.: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.3.5.2. U.S.: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.3.5.3. U.S.: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.3.5.4. U.S.: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.3.6. Gene Therapy Market - Canada
      • 9.3.6.1. Canada: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.3.6.2. Canada: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.3.6.3. Canada: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.3.6.4. Canada: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • 9.4. Gene Therapy Market - Europe
    • 9.4.1. Europe: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 9.4.2. Europe: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
    • 9.4.3. Europe: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
    • 9.4.4. Europe: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.4.5. Gene Therapy Market - UK
      • 9.4.5.1. UK: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.4.5.2. UK: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.4.5.3. UK: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.4.5.4. UK: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.4.6. Gene Therapy Market - France
      • 9.4.6.1. France: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.4.6.2. France: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.4.6.3. France: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.4.6.4. France: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.4.7. Gene Therapy Market - Germany
      • 9.4.7.1. Germany: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.4.7.2. Germany: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.4.7.3. Germany: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.4.7.4. Germany: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.4.8. Gene Therapy Market - Italy
      • 9.4.8.1. Italy: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.4.8.2. Italy: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.4.8.3. Italy: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.4.8.4. Italy: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.4.9. Gene Therapy Market - Spain
      • 9.4.9.1. Spain: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.4.9.2. Spain: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.4.9.3. Spain: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.4.9.4. Spain: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.4.10. Gene Therapy Market - Netherlands
      • 9.4.10.1. Netherlands: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.4.10.2. Netherlands: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.4.10.3. Netherlands: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.4.10.4. Netherlands: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.4.11. Gene Therapy Market - Austria
      • 9.4.11.1. Austria: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.4.11.2. Austria: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.4.11.3. Austria: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.4.11.4. Austria: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • 9.5. Gene Therapy Market - Asia-Pacific
    • 9.5.1. Asia Pacific: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 9.5.2. Asia Pacific: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
    • 9.5.3. Asia Pacific: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
    • 9.5.4. Asia Pacific: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.5.5. Gene Therapy Market - China
      • 9.5.5.1. China: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.5.5.2. China: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.5.5.3. China: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.5.5.4. China: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.5.6. Gene Therapy Market - India
      • 9.5.6.1. India: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.5.6.2. India: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.5.6.3. India: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.5.6.4. India: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.5.7. Gene Therapy Market - Malaysia
      • 9.5.7.1. Malaysia: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.5.7.2. Malaysia: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.5.7.3. Malaysia: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.5.7.4. Malaysia: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.5.8. Gene Therapy Market - Japan
      • 9.5.8.1. Japan: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.5.8.2. Japan: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.5.8.3. Japan: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.5.8.4. Japan: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.5.9. Gene Therapy Market - Indonesia
      • 9.5.9.1. Indonesia: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.5.9.2. Indonesia: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.5.9.3. Indonesia: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.5.9.4. Indonesia: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.5.10. Gene Therapy Market - South Korea
      • 9.5.10.1. South Korea: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.5.10.2. South Korea: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.5.10.3. South Korea: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.5.10.4. South Korea: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • 9.6. Gene Therapy Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 9.6.2. Middle East & Africa: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
    • 9.6.3. Middle East & Africa: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
    • 9.6.4. Middle East & Africa: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.6.5. Gene Therapy Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.6.5.2. Saudi Arabia: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.6.5.3. Saudi Arabia: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.6.5.4. Saudi Arabia: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.6.6. Gene Therapy Market - UAE
      • 9.6.6.1. UAE: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.6.6.2. UAE: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.6.6.3. UAE: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.6.6.4. UAE: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.6.7. Gene Therapy Market - Israel
      • 9.6.7.1. Israel: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.6.7.2. Israel: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.6.7.3. Israel: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.6.7.4. Israel: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.6.8. Gene Therapy Market - South Africa
      • 9.6.8.1. South Africa: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.6.8.2. South Africa: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.6.8.3. South Africa: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.6.8.4. South Africa: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
  • 9.7. Gene Therapy Market - Latin America
    • 9.7.1. Latin America: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 9.7.2. Latin America: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
    • 9.7.3. Latin America: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
    • 9.7.4. Latin America: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.7.5. Gene Therapy Market - Mexico
      • 9.7.5.1. Mexico: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.7.5.2. Mexico: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.7.5.3. Mexico: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.7.5.4. Mexico: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.7.6. Gene Therapy Market - Brazil
      • 9.7.6.1. Brazil: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.7.6.2. Brazil: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.7.6.3. Brazil: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.7.6.4. Brazil: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)
    • 9.7.7. Gene Therapy Market - Argentina
      • 9.7.7.1. Argentina: Gene Therapy Market, By Therapeutic Area, 2016 - 2028 (USD Million)
      • 9.7.7.2. Argentina: Gene Therapy Market, By Vector Type, 2016 - 2028 (USD Million)
      • 9.7.7.3. Argentina: Gene Therapy Market, By Approach, 2016 - 2028 (USD Million)
      • 9.7.7.4. Argentina: Gene Therapy Market, By Route of Administration, 2016 - 2028 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisition
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Novartis AG
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Spark Therapeutics LLC
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Bluebird Bio
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Gilead Sciences Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Celgene Corporation
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. GlaxoSmithKline
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Sangamo Biosciences
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Voyager Therapeutics
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Dimension Therapeutics
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Therapeutic Areas/Product Benchmarking
    • 11.9.4. Recent Development
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.